IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of comprehensive income

in CHF 1 000

 

Notes

 

01.01.–31.03.2022

 

01.01.–31.03.2021

Operating income

 

 

 

 

 

 

Net gains from securities

 

4

 

 

235 555

Foreign exchange gains

 

 

 

720

 

207

Other income

 

 

 

3

 

3

 

 

 

 

723

 

235 765

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

Net losses from securities

 

4

 

(288 406)

 

Finance expenses

 

 

 

(248)

 

(43)

Administrative expenses

 

7

 

(10 485)

 

(13 078)

Other expenses

 

 

 

(1 426)

 

(1 677)

 

 

 

 

(300 565)

 

(14 798)

Profit/(loss) before tax

 

8

 

(299 842)

 

220 967

 

 

 

 

 

 

 

Income taxes

 

 

 

(19)

 

(19)

Profit/(loss) for the period

 

 

 

(299 861)

 

220 948

 

 

 

 

 

 

 

Total comprehensive profit/(loss) for the period

 

 

 

(299 861)

 

220 948

 

 

 

 

 

 

 

Earnings/(loss) per share in CHF

 

 

 

(5.43)

 

3.99

Diluted earnings/(loss) per share in CHF

 

 

 

(5.43)

 

3.99

The notes are an integral part of the condensed consolidated interim financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer